Carla C. Jevoux

Rio De Janeiro, RJ, Brazil

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications

Molecular Mechanisms of Glucocorticoid Action in Migraine: A Systematic Review of Neuroinflammatory and Vascular Pathways.

Molecular Mechanisms of Glucocorticoid Action in Migraine: A Systematic Review of Neuroinflammatory and Vascular Pathways.

Journal: Cureus
Published: November 04, 2025

Medication overuse headache: position statement of specialized headache centers in Brazil.

Medication overuse headache: position statement of specialized headache centers in Brazil.

Journal: Frontiers in pain research (Lausanne, Switzerland)
Published: September 24, 2025

Predictors of Response to Treatment With Anti-calcitonin Gene-Related Peptide (CGRP) Antibodies in Real-World Patients With Episodic Migraine: A Two- and Four-Month Prospective Study.

Predictors of Response to Treatment With Anti-calcitonin Gene-Related Peptide (CGRP) Antibodies in Real-World Patients With Episodic Migraine: A Two- and Four-Month Prospective Study.

Journal: Cureus
Published: March 09, 2025

Skin ecchymosis in migraine patients: a retrospective and exploratory study.

Skin ecchymosis in migraine patients: a retrospective and exploratory study.

Journal: Postgraduate medicine
Published: November 28, 2024

One-Year and Five-Year Outcomes in Medication Overuse Headache: A Real-World Study.

One-Year and Five-Year Outcomes in Medication Overuse Headache: A Real-World Study.

Journal: Cureus
Published: October 24, 2024

Cluster headache and galcanezumab: the first real-world Brazilian study and an expert consensus on its use among other treatments.

Cluster headache and galcanezumab: the first real-world Brazilian study and an expert consensus on its use among other treatments.

Journal: The journal of headache and pain
Published: August 25, 2024

Medication Overuse Headache, Chronic Migraine and Monoclonal Antibodies Anti-CGRP: A Real-World Study.

Medication Overuse Headache, Chronic Migraine and Monoclonal Antibodies Anti-CGRP: A Real-World Study.

Journal: Clinical neuropharmacology
Published: September 25, 2023

"Growing pains" in children and adolescents as an early symptom of migraine: A prospective study.

"Growing pains" in children and adolescents as an early symptom of migraine: A prospective study.

Journal: Headache
Published: February 05, 2023

Monoclonal antibodies for chronic migraine and medication overuse headache: A real-world study.

Monoclonal antibodies for chronic migraine and medication overuse headache: A real-world study.

Journal: Frontiers in neurology
Published: December 22, 2022

Medication-overuse headache-a review of different treatment strategies.

Medication-overuse headache-a review of different treatment strategies.

Journal: Frontiers in pain research (Lausanne, Switzerland)
Published: November 20, 2022

Psychosis and Bilateral Peripheral Facial Palsy Associated With COVID-19.

Psychosis and Bilateral Peripheral Facial Palsy Associated With COVID-19.

Journal: Journal of medical cases
Published: July 18, 2022

Brazilian descriptive study of 104 consecutive real-world migraine patients treated with monoclonal antibodies.

Brazilian descriptive study of 104 consecutive real-world migraine patients treated with monoclonal antibodies.

Journal: Postgraduate medicine
Published: May 18, 2022
Showing 1-12 of 27

Last Updated: 09/26/2026